title: Impact of theophylline/corticosteroid combination therapy on sputum hydrogen sulfide levels in patients with COPD.
authors: National Heart and Lung Institute, Imperial College London, London.
authors: Paul A
authors: PA
authors: Kirkham
authors: Matthew
authors: M
authors: Whiteman
authors: Paul G
authors: PG
authors: Winyard
authors: Gaetano
authors: G
authors: Caramori
authors: Fabiana
authors: F
authors: Gordon
authors: Paul A
authors: PA
authors: Ford
authors: Peter J
authors: PJ
authors: Barnes
authors: Ian M
authors: IM
authors: Adcock
authors: Kian Fan
authors: KF
authors: Chung
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D015415:Biomarkers / Q000378:metabolism; D001993:Bronchodilator Agents / Q000627:therapeutic use; D018450:Disease Progression; D005541:Forced Expiratory Volume; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006862:Hydrogen Sulfide / Q000032:analysis*; D007249:Inflammation; D016877:Oxidants / Q000737:chemistry; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000378:metabolism; D013183:Sputum / Q000737:chemistry*; D013806:Theophylline / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D015415:Biomarkers; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D016877:Oxidants; D013806:Theophylline; D006862:Hydrogen Sulfide